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Abstract
Background: New HIV infections in men who have sex with men (MSM) have increased in Switzerland since 2000 despite
combination antiretroviral therapy (cART). The objectives of this mathematical modelling study were: to describe the
dynamics of the HIV epidemic in MSM in Switzerland using national data; to explore the effects of hypothetical prevention
scenarios; and to conduct a multivariate sensitivity analysis.
Methodology/Principal Findings: The model describes HIV transmission, progression and the effects of cART using
differential equations. The model was fitted to Swiss HIV and AIDS surveillance data and twelve unknown parameters were
estimated. Predicted numbers of diagnosed HIV infections and AIDS cases fitted the observed data well. By the end of 2010,
an estimated 13.5% (95% CI 12.5, 14.6%) of all HIV-infected MSM were undiagnosed and accounted for 81.8% (95% CI 81.1,
82.4%) of new HIV infections. The transmission rate was at its lowest from 1995–1999, with a nadir of 46 incident HIV
infections in 1999, but increased from 2000. The estimated number of new infections continued to increase to more than
250 in 2010, although the reproduction number was still below the epidemic threshold. Prevention scenarios included
temporary reductions in risk behaviour, annual test and treat, and reduction in risk behaviour to levels observed earlier in
the epidemic. These led to predicted reductions in new infections from 2 to 26% by 2020. Parameters related to disease
progression and relative infectiousness at different HIV stages had the greatest influence on estimates of the net
transmission rate.
Conclusions/Significance: The model outputs suggest that the increase in HIV transmission amongst MSM in Switzerland is
the result of continuing risky sexual behaviour, particularly by those unaware of their infection status. Long term reductions
in the incidence of HIV infection in MSM in Switzerland will require increased and sustained uptake of effective
interventions.
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Introduction
Annual numbers of new HIV diagnoses in Switzerland
according to surveillance data were lower in 2010 than in 2000
for all transmission risk groups except men who have sex with men
(MSM) [1]. Furthermore, a nationwide genetic linkage study
found that the majority of clusters representing ongoing transmis-
sion in Switzerland were linked to MSM [2]. The numbers of new
notifications of HIV infection in MSM have been increasing since
2000 in several other high income countries [3]. Contemporane-
ous outbreaks of sexually transmitted infections (STI) among
MSM such as syphilis, rectal gonorrhoea and lymphogranuloma
venereum support the concern that these new cases represent
increasing HIV transmission rather than increased diagnosis of
people infected for a long time [3–5]. All other things being equal,
the incidence of HIV infection would be expected to have fallen in
countries with long term unrestricted access to combination
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antiretroviral therapy (cART), which suppresses viral replication
and reduces the sexual transmission of HIV between heterosexual
couples with discordant infection status [6–8]. Furthermore,
associations have been reported between a reduction in estimated
measures of ‘community viral load’ and numbers of new HIV
infections at the population level in different risk groups and
countries [9,10]. These data have provided support for proposals
to expand the use of cART as a preventive strategy [11].
An increase in the incidence of HIV amongst MSM, despite
cART for those who are infected and diagnosed, could result from
increasing risk behaviour in HIV-negative or HIV-positive men.
Levels of unprotected anal sex have increased in Switzerland [12–
14], as have the numbers of syphilis and gonorrhoea diagnoses in
MSM [15], despite regular ongoing health promotion campaigns.
In 2008, an innovative nationwide safer sex campaign called
‘Mission Possible’ was carried out [16]. The goal was to interrupt
the transmission of HIV during primary infection by having a
three month period of 100% adherence to safer sex for all MSM
followed by an HIV test and advice about risk reduction. A process
evaluation found that awareness of primary HIV infection
increased and 11% of MSM surveyed said that they had had
only safer sex during the campaign [16].
More frequent HIV testing or greater test uptake, higher
numbers of infected MSM from abroad, or prolonged survival,
which increases the pool of infected people could also contribute to
the higher observed number of HIV-infected MSM. Mathematical
modelling studies are a useful tool for investigating the balance
between these different and, sometimes opposing effects [17].
When the benefits of cART on infectivity of and survival with HIV
were still uncertain, Blower and colleagues showed how optimistic
and pessimistic assumptions resulted in divergent predictions of
HIV incidence [18]. More recently, in the face of increasing
number of new HIV diagnoses in MSM in the Netherlands,
modelling studies by Bezemer and colleagues have found that
increasing risk behaviour since the introduction of cART,
particularly by those unaware that they were HIV-positive, was
the most likely explanation for the observed increase in the
number of diagnoses [19,20].
The objectives of this study were: to describe the dynamics of
the HIV epidemic in MSM in Switzerland using data from
national surveillance and clinical cohort databases; to explore how
the epidemic could develop in the future under various
hypothetical scenarios; and to test rigorously the dependence of
the model predictions on different underlying parameter assump-
tions in a multivariate sensitivity analysis.
Materials and Methods
The basic mathematical model structure was that developed by
Bezemer and colleagues [19,20]. Here we present essential
features and describe in detail the adaptations that use Swiss
data, or involve new analyses. The model parameters are shown in
Table S1. In brief, the model describes HIV transmission,
progression and the effects of cART using a set of differential
equations written in C (Open Watcom Integrated Development
Environment Version 1.7). Maximum likelihood methods were
used to fit the model simultaneously to available surveillance data
about HIV infections and AIDS cases in Switzerland and thus re-
construct the epidemic curve since 1980.
Model Structure
HIV progression is represented as a unidirectional flow through
five compartments (stages) with a mean stay of 1.9 years in each
(Figure 1). This structure provides the best fit for an Erlang
distribution with degree 5 to the observed survival distribution of
MSM seroconverters with untreated HIV infection [20]. The
stages do not therefore correspond directly to clinical disease stages
or CD4 count categories. Primary HIV infection lasting on
average 0.2 years is an extra compartment. HIV infectiousness,
relative to that in asymptomatic infection (stages 1 to 4), was
estimated to be 25 times higher in the primary stage and 3.2 times
higher in stage 5, which was assumed to represent AIDS [19–21].
After primary infection, infections in each stage can be
undiagnosed or diagnosed. During the cART era, diagnosed
infections can be untreated or treated. As a result of treatment,
viral suppression is achieved. During viral suppression, it is
assumed that no disease progression and, importantly, no onwards
transmission takes place. Viral suppression can be either perma-
nent or transient with periods of viral rebound when transmission
and disease progression can occur. Viral rebound is assumed to be
permanent after three cycles of viral suppression and rebound
(equivalent to first-, second- and third-line therapy) and infection
then progresses to death from HIV-related causes. We also
assumed that there was no loss to follow up.
HIV infectiousness is also modified by knowledge of HIV
diagnosis. MSM diagnosed from 1984 to 1996 were assumed to
reduce their risk behaviour by 53% after becoming aware of their
infection [22]. The model was adapted for this study to
incorporate new data suggesting a smaller reduction in risk
behaviour following HIV diagnosis of 15% after 1996 [23].
It is assumed that the population susceptible to HIV infection is
large, and that removal of the small proportion that becomes
infected has a negligible effect on the size of the susceptible
population. There is, therefore, no need to introduce susceptibles
into the model. The rate of new infections in the model depends
on the number of individuals with HIV stratified by disease stage
and diagnosis or treatment status [20]. The total rate is calculated
as the sum of the number of individuals in each compartment
weighted by the relative infectiousness of the compartment
multiplied by the net transmission rate.
Viral Suppression and Rebound in Swiss MSM
The effects of cART on prognosis were modelled using data
about rates of viral suppression and rebound. We analysed
longitudinal viral load data from MSM diagnosed after 1998 in the
Swiss HIV Cohort Study (SHCS) to estimate rates and proportions
of viral suppression and rebound at different stages of disease and
in different cycles of cART (Table 1). The SHCS data were
consistent with the three cycles of viral suppression and rebound in
the model. The time from HIV diagnosis or from the start of an
episode of viral rebound to achieving viral suppression (HIV RNA
,1000 copies/ml) was described using Weibull or log-normal
survival models. The time to viral rebound after having achieved
suppression was described by ‘relative survival models’ (also known
as ‘cure’ models), which allow for a proportion of patients never
experiencing viral rebound [24]. For patients with viral rebound,
we assumed that progression continued at the same rate as in
untreated patients. We also assumed that mono or dual therapy
did not slow disease progression. The average rates of viral
rebound and suppression incorporate the effects of drug resistance
and changes over time in criteria for starting cART. To be able to
estimate different rates that could be applied to different stages in
the model, we assumed that stages 1–3 corresponded to individuals
with CD4.250 cells/mm3 at diagnosis, stage 4 corresponded to
CD4,250 cells/mm3 at diagnosis and stage 5 included all patients
with AIDS at diagnosis, irrespective of CD4 count. Model outputs
remained almost identical when using 500 copies/ml as threshold
HIV in Men Who Have Sex with Men in Switzerland
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Figure 1. Model structure. Flow diagram of the mathematical model for HIV transmission amongst men who have sex with men (MSM) in
Switzerland (adapted from [20]). The model describes progression through different stages of untreated and treated HIV infection. Arrows represent
the flow between compartments at rates denoted by Greek letters. Parameter values are given in Table S1.
doi:10.1371/journal.pone.0044819.g001
Table 1. Estimated rates (per year) of viral suppression and viral rebound and fraction experiencing rebound in SHCS participants
(n = 1729).
Description of parameter Value
Range used in sensitivity
analysis
Rate of starting therapy and achieving viral suppression in stages 1, 2, and 3, all cycles 0.7 0.6–0.8
Rate of starting treatment and achieving viral suppression in stage 4, all cycles 2.8 2.5–3.2
Rate of starting treatment and achieving viral suppression in stage 5, all cycles 4 3–5
Rate of viral rebound cycle 1, all stages 0.4 0.3–0.5
Rate of viral rebound cycle 2 and 3, all stages 1.4 1.1–1.7
Fraction with viral rebound cycle 1, stage 1 to 3 0.6 0.5–0.7
Fraction with viral rebound cycle 1, stage 4 and 5 0.3 0.2–0.4
Fraction with viral rebound cycle 2 and 3, stage 1 to 5 0.5 0.4–0.6
doi:10.1371/journal.pone.0044819.t001
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for viral suppression although estimates for treatment-related
parameters were different (not shown).
Fitting to Swiss HIV and AIDS Diagnosis Case Reports
We fitted the transmission model simultaneously to different
sources of surveillance data from the Swiss Federal Office of Public
Health. These included the numbers of new HIV diagnoses from
1995 to 2010, new AIDS cases from 1983 to 1996 and concurrent
(within 60 days) HIV and AIDS diagnoses from 1983 to 2010.
AIDS diagnoses after 1996 were not used to fit the model because
these were affected by the use of cART. However, these data
points could be used to verify the model predictions. Whilst
mandatory reporting of positive HIV diagnoses in Switzerland
dates back to 1988, we only used data from 1995 onwards because
there was over-reporting of case numbers from laboratory reports
in earlier years, which included multiple positive reports from the
same individuals.
The numbers of infections acquired in Switzerland and abroad
were estimated from information collected at HIV diagnosis in
surveillance case reports (2007 onwards) and from the Swiss AIDS
Transmission (CHAT) study in 2005 and 2006 [25,26]. Of
814 MSM included in these data sources, 18% were reported to
have acquired their infection abroad, and 62% from a partner in
Switzerland (20% of responses missing). Of those reporting the
country of infection, 84% of men with Swiss nationality and 66%
of those with foreign nationality were reported to have been
infected in Switzerland. Overall, we estimated that 77% of HIV
infections amongst MSM were acquired in Switzerland.
The model was solved numerically using a Runge-Kutta 4
algorithm and fitted using maximum likelihood methods [19,20].
To define the likelihood, we assumed that numbers of HIV and
AIDS cases were Poisson distributed around a mean defined by
the model as in Bezemer et al. [20]. For convenience, instead of
maximising the likelihood, we minimised the equivalent deviance
measure. We used the downhill simplex optimisation algorithm to
find the minimum. The algorithm was started from various
starting values to ensure that the optimisation was robust and that
local optima were avoided. The fitting procedure resulted in the
estimation of twelve unknown parameters (with 95% confidence
intervals, CI) that are used to interpret the epidemic. The analysis
of the model was done in different time periods, as defined by
Bezemer and colleagues [19,20]: 1980–1983; 1984–1994; 1995–
1999; 2000–2004. In this study, the current cART era was
considered as the most recent period, 2005–2010. The epidemic
was assumed to have started with cases imported from abroad in
1980. The number of imported cases was estimated in three
different time periods: 1980–1983, 1984–2004, and 2005–2010.
Model Outputs
We used the best-fit model to estimate the following outputs:
number of new HIV infections in each calendar year; proportion
of infected patients remaining undiagnosed; proportion of new
infections transmitted by undiagnosed patients; HIV diagnosis
rate; net transmission rate; reproduction number.
The HIV diagnosis rate was set at zero from 1980–1983
because there was no serological test. HIV diagnosis was assumed
to occur within one month of developing AIDS. It was also
assumed that no HIV diagnosis is possible during primary
infection when the antibody response has not fully developed
yet. The mean time to diagnosis was calculated from the diagnosis
rate. The net transmission rate, b(t), measures the rate at which an
infectious HIV-positive individual infects new individuals, relative
to the situation at the beginning of the epidemic [19,20]. This
parameter is an approximate measure of the risk behaviour rate as
it incorporates changes in the partner change rate, in sexual risk-
taking behaviours such as lack of condom use or serosorting, and
the effects on transmissibility of co-existing sexually transmitted
infections. The transmission rate was assumed to be the same for
infections acquired in Switzerland and abroad. Other factors
affecting transmissibility related to awareness of diagnosis, stage of
infection and treatment were already taken into account in the
model. An important assumption is that the overall incidence is
not affected by epidemic saturation effects, which means that the
transmission rate can be averaged across heterogeneous groups
with different risk behaviours. The reproduction number, R(t), is
the average number of people a man infected with HIV in
Switzerland at time t would infect over his whole infectious
lifespan if conditions remained the same at time t [27]. R(t) has to
be below 1 for the epidemic to be controlled. Note that in the
presence of infections acquired abroad, incidence can increase
even when R(t),1, especially when R(t) is close to 1. These
increases are much slower than when R(t).1, when the epidemic
grows exponentially. R(t) is calculated from the best fit values of
parameters describing infectiousness, diagnosis rates and the net
transmission rate.
Hypothetical Scenarios
We used the model to explore the effects of changing certain
input parameters to represent different kinds of interventions. We
implemented an intervention based on ‘Mission Possible’ with
10%, 50%, or 100% of MSM having 3 months of safe sex
(assuming the net transmission rate to be zero) followed by an HIV
test, every year starting in 2011. We also implemented a scenario
with annual HIV testing, on average, and immediate treatment,
i.e. ‘test and treat’ [28] (assuming an exponential time to the next
test with mean one year). We compared these two prevention
scenarios with two other scenarios in which the net transmission
rate was reduced to the levels of the 1984–1994 or the 1995–1999
historical periods.
Multivariate Sensitivity Analysis
We added to the basic transmission model of Bezemer et al.
[19,20] a multivariate sensitivity analysis to investigate the impact
of assumptions about input parameters on the model predictions
using a method that extends the Latin Hypercube sampling
method [29]. For each of the 45 fixed input parameters, we
identified a range of plausible values based on literature or on data
from the SHCS cohort (Figure 1, Table 1, Table S1). We
partitioned each parameter into 250 equidistant possible values
spanning its whole plausible range. The sensitivity of the model to
its fixed input parameters was then evaluated by sampling from
the range of possible parameter values. Parameter values were
sampled from a Latin Hypercube such that each possible value
was sampled exactly once. We extended the Latin hypercube
sampling method [29] by refitting the model to the data for each
parameter set and re-estimating the twelve unknown parameters;
in this way we explore a wide range of input parameters, but only
with the restricted set of scenarios that best fit the epidemic data.
Partial rank correlation coefficients (PRCCs) were calculated for
the correlation between each input parameter and the net
transmission rate b(t). In general, PRCC values near 1 (or 21)
indicate a strong positive (or negative) influence of the input
parameter on b(t), whilst values near 0 indicate little influence. We
conducted the sensitivity analysis for the main results and the
hypothetical scenarios.
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Results
Using the best-fit model, we produced curves of the numbers of
diagnosed HIV infections and AIDS cases in MSM that fitted the
observed data well, including reported AIDS cases from 1996
onwards, which were not used for fitting (Figures 2A and 2B).
Figure 2C shows the predicted numbers of incident HIV infections
in MSM in Switzerland. According to the best-fit model, this
peaked in 1983 with approximately 800 new infections, reached a
nadir of about 50 in 1999 and has continued to increase since
then. Figure 2D shows that the estimated number of MSM living
with HIV remained at about 2000 for almost a decade (1987 to
1998). The total number of MSM estimated to be living with HIV
in Switzerland has steadily increased during the cART era and
more than doubled to 5229 (95% CI 5147, 5313). We estimated
that by the end of 2010, 13.5% (95% CI 12.5, 14.6%) of all HIV-
infected MSM had not yet been diagnosed and were thus unaware
of their infection (Figure 3A). These MSM accounted for 81.8%
(95% CI 81.1, 82.4%) of new HIV infections (Figure 3A).
The changes in the net transmission rate and time to diagnosis
that we estimated using the model are shown in Figure 3B and 3C.
Figure 3D shows corresponding changes in the estimated
reproduction number. The highest transmission rate occurred in
the earliest phase from 1980–1983 when there was no HIV
diagnosis or treatment; during this phase the reproduction number
R(t) was estimated to be 2.72 (95% CI 2.52, 2.90). The largest
decrease in the net transmission rate occurred from 1984–1994,
associated with the introduction of HIV testing and the
assumption of reduced sexual risk taking after receiving an HIV
diagnosis. During this phase the transmission rate fell by an
estimated 65% (95% CI 63, 67%), the mean time from infection to
diagnosis decreased to 3.5 (95% CI 3.3, 3.7) years and the
reproduction number declined to 0.82 (95% CI 0.77, 0.86), which
is below the epidemic threshold. This resulted in a plateau in the
observed annual number of new infections at around 200 per year
from 1984–1994 (Figure 2C).
In the early cART period from 1995–2000, the net transmission
rate and the reproduction number (0.43, 95% CI 0.34, 0.51) were
at their lowest (Figure 3B, 3D). From 2000–2005 the transmission
rate increased to 49% (95% CI 46, 51%) of its initial value in
1980–1983, resulting in an increase in the reproduction number to
0.85 (95% CI 0.81, 0.89). This increase in transmission rate was
observed for each of the 250 parameter sets in the multivariate
sensitivity analysis. From 2005–2010, there were small reductions
in the net transmission rate and reproduction number. Although
the reproduction number has been below the epidemic threshold
since 2000, the estimated number of annual new infections has
continued to increase, to more than 250 in 2010 (Figure 2C).
Hypothetical Scenarios
The potential development of the HIV epidemic in MSM in
Switzerland from 2011 onwards under different scenarios is shown
in Figures 4A and 4B. If conditions do not change the incidence
would carry on rising to more than 300 infections per year, which
would result in 8654 MSM living with HIV by 2020. ‘Mission
Possible’ scenarios repeated yearly with 10%, 50%, and 100% of
MSM having safe sex for 3 months followed by an HIV test, would
reduce HIV incidence below the 2010 level and prevent 167, 882,
and 1673 new infections, respectively by 2020 (Figure 4A). A
strategy of ‘test and treat’ in which the average time from infection
to diagnosis is reduced to 1 year, assuming cART is started
immediately and viral suppression is achieved within one month
after diagnosis, would reduce HIV incidence to 199 infections per
year by 2020 thus preventing 1028 new infections. More marked
reductions in HIV incidence would be achieved if the risk
behaviour rate fell to the levels attained in 1984–1994 or 1995–
1999 (Figure 4B); the annual HIV incidence would fall to 133 and
61 new infections, respectively in 2020 (1562 and 2273 new
infections prevented by 2020), and the reproduction number to
0.62 and 0.40, respectively. However, under all considered
scenarios the number of MSM living with HIV would continue
to increase due to the decreased mortality since the advent of
cART.
Multivariate Sensitivity Analysis
The parameters related to disease progression and the relative
infectiousness of the different stages of the infection had the largest
influence on the estimates of the net transmission rate b(t) (Table
S2). In particular, PRCC ranged from 20.85 to 20.94 for the
relative infectiousness of primary infection indicating that, for
higher values of this parameter, the estimated net transmission rate
decreased. Similarly, PRCC ranged between 0.88 and 0.94 for the
reciprocal of the duration of primary infection, which is the rate aP
at which infected individuals move from primary infection to stage
1 (Figure 1, Table S2). To understand these associations it should
be noted that, for higher values of aP, the duration of primary
infection gets shorter and this is compensated for by a higher
estimate of the transmission rate in order to generate a certain
number of HIV diagnoses and AIDS cases. Analogously, a higher
infectiousness of primary infection is compensated for by lower
estimates of b(t).
Discussion
This study shows that the HIV epidemic amongst MSM in
Switzerland has been increasing since the year 2000. The model
suggests that the increase in new infections results predominantly
from an increase in the transmission rate, and that the majority of
new infections are transmitted by MSM unaware of their infection.
Testing rates have increased steadily over the period of the
epidemic and the time to diagnosis has decreased.
The main strength of this study is the use of empirical data from
a national surveillance system and clinical cohort, which could be
adapted for use using a previously developed model [19,20]. The
model, previously used in the Netherlands, could be used in
Switzerland because both countries have HIV epidemics that are
concentrated in MSM and both countries have HIV surveillance
systems that collect data on new HIV diagnoses acquired within
country and abroad, new AIDS diagnoses and simultaneous HIV
and AIDS diagnoses. An additional strength of the current analysis
is the multivariate sensitivity analysis, which supplements the
earlier univariable sensitivity analysis for the model [20] and
extends the widely used Latin hypercube sampling method [29].
There are limitations to our study related to biases in the
surveillance data. Our reconstruction of the earlier years of the
epidemic is not very precise because the numbers of HIV case
reports before 1995, which were known to be unreliable, were not
used for fitting the model. Nevertheless, the predicted numbers
fitted the observed data for new HIV diagnoses from 1995
onwards and for AIDS diagnoses well. The model predictions
might not capture trends in the epidemic if sex between men as the
route of transmission has been substantially under-reported or if
HIV-infected MSM who are not registered by the surveillance
system (because they die or emigrate without being registered) are
an important source for transmission. We do not have any
information to support or refute these possible biases. The model
predictions of HIV prevalence are affected by considering only
HIV-related deaths and by ignoring loss to follow-up. The number
HIV in Men Who Have Sex with Men in Switzerland
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of MSM living with HIV infection (Figure 2D) can be considered
an upper bound on the true number.
The most important assumption when interpreting the
outcomes of the model is that the transmission parameter b(t)
can be considered as an average measure of risk behaviour. This
assumption is valid in countries like Switzerland with low HIV
prevalence where saturation effects do not affect the dynamics of
transmission. Whilst there are no representative HIV seropreva-
lence studies in Switzerland, estimates from Europe suggest a
prevalence of 6% or lower [30]. In addition, gene sequencing
studies have identified clusters of HIV infections showing evidence
of recent transmission amongst MSM, which suggest that
saturation has not occurred [2]. Another assumption was that
there is no transmission when viral load is below the level of
detection, defined as ,1000 copies/ml. This allowed data from
the 1990s to be included when 1000 copies/ml was the cut-off of
Figure 2. Model fits and estimates. Model fits to reported HIV and AIDS cases. Panel A) annual HIV diagnoses separated into infections acquired
in Switzerland (black filled squares, dashed line) and abroad (black filled circles, solid line); B) annual number of new AIDS cases (black filled circles,
solid line) and concurrent HIV and AIDS diagnoses (squares, black dashed line). Model estimates: C) annual number of new infections in Switzerland,
D) number of men who have sex in Switzerland living with HIV. Continuous lines show model fit; dashed lines in panels C and D are 95% confidence
intervals. Solid shapes show reported data; black shapes are data points used for fitting, grey shapes are not used for fitting. Grey lines show results of
multivariate sensitivity analyses.
doi:10.1371/journal.pone.0044819.g002
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the viral load assays that were then available. We believe that the
transmission rate at this level of viraemia will come from a very
small group of patients; first because no transmission events were
observed ,400 copies/ml in a meta-analysis of treated patients [7]
and second, most patients will actually have a viral load ,50
copies/ml. A further limitation is that the model does not produce
reliable estimates of the proportions of HIV transmission
occurring during acute primary infection and asymptomatic
infection. This would be a valuable output but it could not be
formulated in the model because of a lack of reliable data about
risk-changing strategies like partner change rates, serosorting, and
serial monogamy at different stages of infection. As a result of such
strategies, the infectiousness of primary infection relative to the
asymptomatic undiagnosed phase may effectively be lower than as
parameterised in our model.
This study is the first to reconstruct the HIV epidemic in Swiss
MSM using a mathematical model. The model predictions
strongly suggest a resurgence of HIV transmission amongst
Figure 3. Model estimates for unknown parameters. A) percentage of infected patients remaining undiagnosed (solid line, dashed lines show
95% confidence interval) and percentage of new infections transmitted by those remaining undiagnosed (dotted line, dashed lines show 95%
confidence interval); B) net transmission rate relative to the period 1980–1983 (dotted line, dashed lines show 95% confidence interval); C) average
time from HIV infection to diagnosis in years (dotted line, dashed lines show 95% confidence interval); D) reproduction number (dotted line, dashed
lines show 95% confidence interval). Grey lines show results of multivariate sensitivity analyses.
doi:10.1371/journal.pone.0044819.g003
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MSM in Switzerland despite increasing levels of HIV testing and
use of cART. The predicted decrease in the average time from
HIV infection to diagnosis is supported by results from the Swiss
Gay Survey 2009, which shows that the estimated proportion of
MSM who had had an HIV test within the last 12 months
increased from 30% in 2007 to 40% in 2009 [6], and the SHCS in
which the median CD4 cell count at diagnosis in MSM has
increased from 387 cells/mm3 (inter-quartile range, 160–521) in
2000 to 441 cells/mm3 (286–598) in 2009. An average of 2.2 years
between infection and diagnosis would still allow for a substantial
amount of HIV transmission, especially if treatment does not start
immediately and if the reduction in risky sexual behaviour
following HIV diagnosis is less than in earlier years [23].
The model outputs suggest that the increase in HIV transmis-
sion amongst MSM in Switzerland is the result of continuing risky
sexual behaviour, particularly by those who are unaware that they
are HIV-infected. In both the Dutch and Swiss studies the model
predicted a high proportion of new infections attributable to
transmission from undiagnosed MSM (in 2006, 90% in the
Netherlands [20], Swiss model 83%). However, despite an
increase in risky sexual behaviour, the within-country reproduc-
tion number is predicted to be below the epidemic threshold from
2005–2010. Still, in the Swiss model, numbers of new HIV
infections are predicted to increase, which is likely to be due to
infections acquired abroad. About 20% of new HIV infections in
MSM in Switzerland are acquired abroad (Figure 2), compared
with about 7% in the Netherlands [31], where local transmission
appeared sufficient to sustain transmission [20]. Within Switzer-
land, there is some empirical support for a recent increase in
sexual risk behaviour amongst MSM. The odds of having
unprotected sex among HIV-infected MSM from the SHCS with
both stable and occasional partnerships increased between 2007
and 2009 [14], whereas an earlier study found no evidence of an
increase in unsafe sexual behaviour from 2000 to 2003 amongst all
transmission groups combined [32]. Analyses from the Swiss Gay
Survey have found reductions in some safer sex behaviours from
1992 to 2004 [13] and, in the 2007 survey, high prevalences of
withdrawal before ejaculation, serosorting, and strategic position-
ing amongst MSM reporting unprotected anal sex with casual
partners [33]. Increases in sexual risk behaviour have further been
associated with HIV optimism following the introduction of cART
[4,34,35].
The predictions from this study have implications for future
prevention strategies. The greatest fall in the HIV transmission
rate occurred during a time when testing and treatment were
introduced, but when there were still frequent visible reminders of
AIDS and its consequences, which probably reinforced the need
for reduced sexual risk behaviour [36]. The gains predicted in the
hypothetical ‘test and treat’ scenario that halves the average time
to diagnosis from the 2010 level rely on the assumption that risk
behaviour levels are constant or decline. The model estimates of
an increasing transmission rate in the cART era, however, support
the prediction that the prevention benefits of cART could be offset
by increases in risk behaviour in untreated individuals [18].
Modest levels of uptake (10%) of a campaign like Mission Possible
could result in a small transient reduction in new HIV diagnoses if
repeated every year. Accurate diagnosis of primary HIV infection
would be an important advance and interventions to reduce the
proportion of undiagnosed individuals and attain long-term
reduction of sexual risk behaviours should be pursued. Long term
reductions in the number of new HIV infections in MSM in
Switzerland will require increased and sustained uptake of effective
interventions.
Figure 4. Hypothetical scenarios for the potential development of the HIV epidemic in Switzerland. Annual HIV incidence: A) without
intervention and under various ‘Mission Possible’ scenarios with 10%, 50%, or 100% of MSM having safe sex for 3 months each year starting in 2011,
followed by an HIV test; B) without intervention, under a ‘test and treat’ strategy (assuming that the average time between infection and diagnosis is
reduced to 1 year and treatment is started immediately), or assuming that the net transmission rate falls to the levels attained in 1984–1994 or 1995–
1999.
doi:10.1371/journal.pone.0044819.g004
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